In patients with annular dimensions suitable for two valve sizes, implantation of a larger SAPIEN 3 transcatheter heart valve (THV) oversized to both annular area and perimeter was associated with lowest incidence of paravalvular regurgitation (PVR) and improved hemodynamics, reports a new analysis from the PARTNER 3 trial.